Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines

Cancer Letters

Volumn 155, Issue 2, 2000, Pages 173-179

  Nagakawa, Osamu ^a,b   Murakami, Koji ^a   Yamaura, Takeshi ^a   Fujiuchi, Yasuyoshi ^a,b   Murata, Jun ^a   Fuse, Hideki ^b   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Gastrin releasing peptide; Hepatocyte growth factor; Invasion; Membrane type metalloproteinase 1; Prostate carcinoma

Indexed keywords

COLLAGENASE; GASTRIN RELEASING PEPTIDE; MESSENGER RNA; SCATTER FACTOR;

ARTICLE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

EID: 0034738824     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00425-0     Document Type: Article

References (34)

1. L.A. Liotta C.N. Rao S.H. Barsky Tumor invasion and the extracellular matrix Lab. Invest. 49 1983 636 649
2. V.P. Terranova E.S. Hujanen G.R. Martin Basement membrane and the invasive activity of metastatic tumor cells J. Natl. Cancer Inst. 77 1986 311 316
3. L.A. Liotta Cancer cell invasion and metastasis Sci. Am. 266 1992 34 41
4. L.A. Liotta Tumor invasion and metastasis: role of the extracellular matrix: Rhoads memorial award lecture Cancer Res. 46 1986 1 7
5. H. Nagase K. Suzuki T. Morodomi J.J. Enghild G. Salveen Activation mechanisms of the precursors of matrix metalloproteinase1, 2 and 3 Matrix 1 1992 237 244
6. H.S. Azzam E.W. Thompson Collagen-induced activation of the M (r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells Cancer Res. 52 1992 4540 4544
7. H. Sato T. Takino Y. Okada J. Cao A. Shinagawa E. Yamamoto M. Seiki Membrane type 1 matrix metalloproteinase expressed on the surface of invasive tumor cells Nature 370 1994 61 65
8. E. Ohuchi K. Imai Y. Fujii M. Sato Y. Okada Membrane type 1 matrix metalloproteinases in metastasis J. Biol. Chem. 272 1997 2446 2451
9. H. Ohtani H. Motohashi H. Sato M. Seiki H. Nagura Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy Int. J. Cancer 68 1997 565 570
10. M. Tokuraku H. Sato S. Murakami Y. Okada Y. Watanabe M. Seiki Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinoma correlates with the expression of membrane-type matrix metaloproteinase (MT-MMP) and with lymph node metastasis Int. J. Cancer 64 1995 355 359
11. C. Gilles M. Polette J. Piette C. Munaut E.W. Thompson P. Birembaut J.M. Foidart High level of MT-MMP expression is associated with invasiveness of cervical cancer cells Int. J. Cancer 65 1996 209 213
12. H. Pulyaeva J. Bueno M. Polette P. Birembaut H. Sato M. Seiki E.W. Thompson MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells Clin. Exp. Metastasis 15 1997 111 120
13. O. Nagakawa M. Ogasawara H. Fujii K. Murakami J. Murata H. Fuse I. Saiki Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells Cancer Lett. 133 1998 27 33
14. K. Nishimura M. Kitamura S. Takada N. Nonomura A. Tsujimura K. Matsumiya T. Miki K. Matsumoto A. Okuyama Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor Int. J. Urol. 5 1998 276 281
15. K. Murakami R. Sakukawa T. Ikeda T. Matsuura S. Hasumura S. Nagamori Y. Yamada I. Saiki Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type1 matrix metalloproteinase Neoplasia 4 1999 1 7
16. K. Murakami T. Matsura M. Sano A. Hashimoto K. Yonekura R. Sakukawa Y. Yamada I. Saiki 4-[3,5-Bis (trimethylsilyl)-benzamido]benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor bearing animals Clin. Exp. Metastasis 16 1998 633 643
17. N. Ata T. Oku M. Hattori H. Fujii M. Nakajima I. Saiki Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells Oncol. Res. 12 1996 503 511
18. I. Saiki J. Murata K. Watanabe H. Fujii F. Abe I. Azuma Inhibition of tumor cell invasion by Ubenimex (Bestatin) in vitro Jpn. J. Cancer Res. 80 1989 873 878
19. K. Saito T. Oku N. Ata H. Miyashiro M. Hattori I. Saiki A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors Biol. Pharm. Bull. 20 1997 345 348
20. R.A. Stephenson C.P.N. Dinney K. Gohji N.G. Ordonez J.J. Kilion I.J. Fidler Metastatic model for human prostate cancer using orthotopic implantation in nude mice J. Natl. Cancer Inst. 84 1992 951 957
21. P. Mignati D.B. Rifkin Biology and biochemistry of proteinases in tumor invasion Physiol. Rev. 73 1993 161 195
22. H. Sakata H. Takayama R. Sharp J.S. Rubin G. Merlino W.J. LaRochelle Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers Cell Growth Differ. 7 1996 1513 1523
23. H. Tajima K. Matsumoto T. Nakamura Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species Exp. Cell Res. 20 1992 423 431
24. F. Bussolino M.F. Di Renzo M. Ziche E. Bocchietto M. Olivero L. Naldini G. Gaudino L. Tamagnone A. Coffer P.M. Comoglio Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth J. Cell Biol. 119 1992 629 641
25. D.P. Bottaro J.S. Rubin D.L. Faketto A.M. Chan T.E. Kmiecik G.F. Vande Woude S.A. Aranson Identification of the hepatocyte growth factor as the c-MET proto-oncogene product Science 251 1991 802 804
26. A.H. Peter Z. Xiaopei Z. Reza E.S. Paul L.R. Timothy T.V. Robin L.D. Mark Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma Am. J. Pathol. 147 1995 386 396
27. S. Kurimoto N. Moriyama S. Horie M. Sakai S. Kameyama Y. Akimoto H. Hirano K. Kawabe Co-expression of hepatocyte growth factor and its receptor in human prostate Cancer Histochem. J. 30 1998 27 32
28. P.A. Di SantAgnese Neuroendocrine differentiation in carcinoma of the prostate Cancer 70 1992 254 268
29. J. Shimoda D. Koh T. Kigure T. Harada S. Tsuchida K. Kudo J. Urol Effect of bombesin and its antibody on human prostatic carcinoma cell line (DU-145, PC-3) J. Urol. 145 1991 400A
30. M. Bologna C. Festuccia P. Muzi L. Biordi M. Ciomei Bombesin stimulates growth of human prostatic cancer cells in vitro Cancer 63 1989 1714 1720
31. S.R. Milovanovic S. Radulovic K. Groot A.V. Schally Inhibition of growth of PC-82 human prostate cancer cell line xenografts in nude mice by bombesin antagonist RC-3095 or combination of agonist [ d -Trp6]-luteinzing hormone-releasing hormone and somatostatin analog RC-160 Prostate 20 1992 269 280
32. A. Jungwirth J. Pinski G. Galvan G. Halmos K. Szepeshazi R.Z. Cai K. Groot M. Vadillo-Buenfil A.V. Schally Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinizing hormone-releasing hormone antagonist cetrorelix and bombesin antagonists RC-3940-II and RC-3950 II Eur. J. Cancer 33 1997 1141 1148
33. N.M. Hooseein C.J. Logothetis L.W. Chung Differential effects of peptide hormones bombesin, vasoactive intestinal polypepides and somatostatin analog RC160 on the invasive capacity of human prostatic carcinoma cells J. Urol. 149 1993 1209 1213
34. C. Festuccia F. Guerra S. D'Ascenzo D. Giunciuglio A. Albini M. Bologna In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin Int. J. Cancer 75 1998 418 431